Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network

Abstract

Patients with PsO/PsA starting with TNF-α inhibitors switch/swap more rapidly and frequently than those with anti-IL, which are also associated with a reduced risk of multiple switches during follow-up.